PAP
LLY icon

Persistent Asset Partners’s Eli Lilly LLY Stock Holding History

Persistent Asset Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
+25
New +$25.5K 0.01% 475
2025
Q4 		– Sell
-23
Closed -$1.85K – 409
2025
Q3 		$1.85K Sell
23
-34,577
-100% -$25.7M ﹤0.01% 232
2025
Q2 		$474K Buy
34,600
+34,552
+71,983% +$26.8M 0.35% 79
2025
Q1 		$215K Buy
+48
New +$39.9K 0.18% 98

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Persistent Asset Partners's LLY Position: Q2 2026 in Review

Persistent Asset Partners reduced its Eli Lilly (LLY) stake by 97% in Q2 2026, selling an estimated $1.89M and leaving 56 shares worth $67.2K. The position accounts for 0.02% of the portfolio, ranked #380.

Persistent Asset Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.71M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Persistent Asset Partners held 56 shares of Eli Lilly worth $67.2K as of Q2 2026.
  • Persistent Asset Partners sold 1,850 Eli Lilly shares in Q2 2026, an estimated $1.89M.
  • Eli Lilly made up 0.02% of Persistent Asset Partners's portfolio in Q2 2026, its #380 holding.
  • Persistent Asset Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Persistent Asset Partners's Eli Lilly position peaked at $3.71M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.